Spin Transfer Technologies, Inc. a leading developer of a breakthrough
MRAM universal computer memory technology announced today that it
secured $36 million in Series A funding. The raise was led by its
Boston-based parent company, Allied Minds and Invesco Asset Management.
Spin Transfer Technologies (STT) will use the funds to scale operations,
purchase equipment and grow its team to accelerate development of its
patented orthogonal spin transfer magneto resistive random access memory
technology (OST-MRAM). The company is poised to create the next
generation of memory applications combining the non-volatility of flash
with the read and write performance of DRAM and SRAM into one, seamless
product. Initial performance data from STT bit cells has far exceeded
industry standards in key areas.
“From servers to mobile platforms, our memory technology has the
potential to significantly boost the performance of nearly all forms of
computing applications. The additional capital we’ve secured will help
further advance our efforts towards development and ultimately
commercialization,” stated Steven Cliadakis, General Manager of Spin
Transfer Technologies.
The potential benefits of the STT approach are significant: superior
processing speed, lower manufacturing cost, greater scalability,
significantly lower power consumption and virtually unlimited endurance.
“Since our initial investment, we continue to witness positive technical
outcomes with the orthogonal spin transfer approach,” said Chris Silva,
CEO of Allied Minds. “These exciting results coupled with the growing
interest among potential collaborators make us confident that STT’s MRAM
technology will gain wide acceptance across the industry.”
About Spin Transfer Technologies
Spin Transfer Technologies, Inc. was established by Allied Minds and New
York University to develop and commercialize its orthogonal spin
transfer magnetoresistive random access memory technology, OST-MRAM. The
technology, discovered by Professor Andrew Kent, has enormous
implications for the development of spin transfer MRAM devices,
including faster switching times, lower power operation and scalability
to smaller dimensions. www.spintransfer.com.
About Allied Minds
Allied Minds is a private equity-funded innovation company that forms,
funds, manages and builds startups based on early-stage technology
developed at renowned U.S. universities and national labs. Allied Minds
serve as a diversified holding company that supports its businesses with
capital, management and shared services and is the premier firm to
utilize this novel and fully-integrated approach to technology
commercialization. Investments span multiple business sectors and offer
an attractive risk-return profile, a deliverable timeline and
groundbreaking products and services. Subsidiaries include Allied Minds
Devices, Biotectix, Cephalogics, CryoXtract, Illumasonix, ProGDerm,
Precision Biopsy, RF Biocidics, SaltCheck, SciFluor Life Sciences,
SiEnergy Systems, SoundCure, and Spin Transfer Technologies. www.alliedminds.com/about

Source(s) : Allied Minds, Inc.